Cargando…
The effect of helix-inducing constraints and downsizing upon a transcription block survival-derived functional cJun antagonist
Inhibition of cJun is established as a promising therapeutic approach, particularly in cancer. We recently developed the “transcription block survival” (TBS) screening platform to derive functional peptide antagonists of transcription factor activity by ablating their ability to bind to cognate DNA....
Autores principales: | Brennan, Andrew, Leech, James T., Kad, Neil M., Mason, Jody M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582194/ https://www.ncbi.nlm.nih.gov/pubmed/36274790 http://dx.doi.org/10.1016/j.xcrp.2022.101077 |
Ejemplares similares
-
Selective antagonism of cJun for cancer therapy
por: Brennan, Andrew, et al.
Publicado: (2020) -
In vitro single molecule and bulk phase studies reveal the AP-1 transcription factor cFos binds to DNA without its partner cJun
por: Leech, James T., et al.
Publicado: (2022) -
Selection and Characterization of a DNA Aptamer That Can Discriminate between cJun/cJun and cJun/cFos
por: Walters, Ryan D., et al.
Publicado: (2014) -
p27 transcriptionally coregulates cJun to drive programs of tumor progression
por: Yoon, Hyunho, et al.
Publicado: (2019) -
An Approach to Derive Functional Peptide Inhibitors
of Transcription Factor Activity
por: Brennan, Andrew, et al.
Publicado: (2022)